Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
In Chicago, Tempus, a tech firm at the forefront of AI in precision medicine, shared findings from the Articulate Pro research in Nature Digital Medicine. This study focused on employing AI to aid pathologists in prostate biopsy assessments. The research delved into assessing the Paige Prostate Suite within Tempus' smart diagnostics system and its incorporation into regular clinical processes. The AI-supported analysis aimed to enhance accuracy in prostate biopsy reporting.